1 year return (CAGR)
-68.67%
Humacyte Inc Exchange (NASDAQ, USD)
HUMA
0.57
-0.01 (-1.22%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-43.52%
5 year return (CAGR)
-48.20%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
161.90M
Price/Sales
76.33
Ent value
188.82M
Price/Book
5.18
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
157.07%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.59 |
| Daily high | 0.61 |
| Daily low | 0.58 |
| Daily Volume | 3.47M |
| All-time high | 16.99 |
| 1y analyst estimate | 1.85 |
| Beta | 2.47 |
| EPS (TTM) | -0.41 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| HUMA | S&P500 | |
| Current price drop from All-time high | -96.67% | -1.29% |
| Highest price drop | -96.76% | -56.47% |
| Date of highest drop | 13 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -77.19% | -10.68% |
| Avg time to new high | 160 days | 12 days |
| Max time to new high | 1269 days | 1805 days |
News
